1. Kuwait Stocks

  2. •

    Distribution services

  3. •

    Medical distributors
Advanced Technology Co.

Advanced Technology Co.

KKSE:ATC
494.00
KWF
-47.00
(-8.69%)
-139.26EPS
132.60BMarket Cap
Advanced Technology Co.
KSE:ATC
(Kuwait Stock Exchange)

Recent

price

494.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2007
2008
2009
2010
2011
2012
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
KWD
0.22
0.28
0.3
0.26
0.26
0.59
0.5
0.85
0.75
0.72
0.72
0.72
0.84
0.85
0.91
0.81
0.75
Revenue per Share
0.02
0.03
0.03
0.02
0.02
0.02
0.03
0.04
0.03
0.01
0.02
0.03
0.04
0.03
- -
-0.08
-0.12
Basic EPS, GAAP
0.02
-0.04
- -
- -
- -
-0.01
-0.06
-0.1
-0.22
0.11
-0.07
0.01
0.17
0.12
-0.01
0.1
0.15
Free Cash Flow per Basic Share
0.01
0.02
0.01
- -
- -
- -
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.02
- -
- -
Dividend per Share
0.14
0.15
0.17
0.2
0.17
0.19
0.25
0.27
0.29
0.29
0.31
0.32
0.35
0.36
0.36
0.27
0.22
Book Value per Share
0.14
0.15
0.17
0.2
0.17
0.19
0.25
0.27
0.15
0.14
0.16
0.18
0.22
0.14
0.14
0.06
- -
Tangible Book Value per Share
183
162
165
198
198
198
198
198
198
198
198
198
198
198
198
197
197
Basic Weighted Avg Shares
40
45
50
52
52
117
99
168
149
142
143
142
166
169
179
160
147
Sales/Revenue/Turnover
15.08
14.58
13.86
12.54
10.75
52.49
9.27
7.65
10.98
8.56
8.58
8.11
8.52
7.78
5.67
-6.83
-12.26
Operating Margin (%)
3
4
3
4
4
4
6
6
6
8
7
8
7
9
11
12
12
Depreciation Expense
4
5
5
5
4
4
6
8
7
2
4
5
7
5
1
-16
-23
Net Income, GAAP
1.9
4.6
4.79
5.2
5.8
3.69
6.66
5.08
6.4
10.96
10.42
11.47
6.79
3.5
- -
- -
- -
Effective Tax Rate (%)
11.01
10.95
10
8.96
6.93
3.49
5.91
4.84
4.46
1.3
2.78
3.73
4.24
2.98
0.39
-10.13
-15.49
Profit Margin (%)
10
13
13
18
24
17
40
45
61
62
57
89
79
55
72
40
10
Working Capital
2
2
1
2
- -
- -
11
13
26
31
27
50
39
60
87
79
60
LT Debt
21
23
26
31
34
37
49
54
58
58
61
64
69
72
68
46
34
Total Equity
22.37
19.62
16.41
14.92
12.69
13.05
9.69
8.39
7.71
4.69
4.24
4.15
5.79
5.47
- -
- -
- -
Return on Invested Capital (%)
21.74
19.29
16.09
14.62
12.12
8.95
9.46
8.21
6.41
3.73
3.9
4.03
5.32
6.59
- -
- -
- -
Return on Capital (%)
22.11
22.22
20.35
16.28
11.12
11.48
13.68
15.84
11.83
3.19
6.71
8.51
10.52
7.12
0.99
-26.3
-41.51
Return on Common Equity (%)

Capital Structure

KWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
133
131
131
LT Borrowings
78
72
59
LT Finance Leases
1
1
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
195
195
195
Market Capitalization
116
99
133

Working Capital

KWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
220
206
195
Cash, Cash Equivalents & STI
5
4
3
Accounts Receivable, Net
154
137
127
Inventories
49
50
46
Total Current Liabilities
180
177
185
Payables & Accruals
- -
- -
- -
ST Debt
133
131
131
Deferred Revenue
- -
- -
- -

Growth Rates

KWD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
3.36%
-4.13%
-32.98%
Free Cash Flow
37.38%
30.12%
-789.22%
Net Income, GAAP
-234.95%
-491.24%
-2,407.82%
Sales/Revenue/Turnover
5.22%
2.71%
-10.52%
Total Cash Common Dividend
- -
-2.76%
-99.82%

Quarterly Revenue

KWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
41
46
50
42
179
2025
34
46
40
40
160
2026
30
36
- -
- -
- -

Quarterly Earnings Per Share

KWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
-0.01
- -
- -
-0.06
-0.08
2026
-0.02
-0.03
- -
- -
- -

Quarterly Dividends Per Share

KWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.02
- -
- -
0.02
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
DataMeds AI, Inc. (NASDAQ:MEDS)
Selcuk Ecza Deposu Ticaret ve Sanayi A.S. (BIST:SELEC)
McKesson Corporation (NYSE:MCK)
Ibnsina Pharma (EGX:ISPH)
Cardinal Health, Inc. (NYSE:CAH)
Entero Healthcare Solutions Limited (NSE:ENTERO)
Business
Advanced Technology Company K.S.C.P. (KSE: ATC) is a Kuwait-based end-to-end healthcare and life sciences solutions provider engaged in the procurement, distribution, installation, and maintenance of medical, laboratory, dental, pharmaceutical, and environmental equipment and supplies. Founded in 1981 and headquartered in Salmiya, Kuwait, the company operates across multiple specialized business segments: Medical Equipment, providing diagnostic imaging systems, surgical units, critical care devices, patient monitoring apparatus, anesthesia workstations, and hospital furniture; Laboratory Diagnostics, offering clinical chemistry analyzers, molecular diagnostics, hematology systems, microbiology equipment, life sciences research instrumentation, and specialized reagents; Dental Solutions, supplying dental operatory chairs, CAD/CAM dentistry systems, digital dental imaging, surgical handpieces, and consumables; Pharmaceuticals and Consumables, distributing prescription therapeutics, hospital consumables, sterilization products, and infection control supplies; Healthcare Information Technology, delivering hospital information systems (HIS), picture archiving and communication systems (PACS), laboratory information systems (LIS), and digital health software; and Environmental and Scientific Systems, providing water quality testing, ambient air monitoring instrumentation, and food safety testing equipment. The company also provides comprehensive turnkey project execution, biomedical engineering support, preventive maintenance, calibration services, and clinical training. ATC primarily serves public health institutions, including the Kuwait Ministry of Health and Ministry of Defense hospitals, as well as private hospital networks, specialized medical clinics, research laboratories, and academic institutions across Kuwait and the broader Gulf Cooperation Council (GCC) region. In recent developments, the company has expanded its regional presence by scaling operations in Saudi Arabia to capture growing demand under healthcare transformation initiatives, formed strategic distribution alliances for next-generation artificial intelligence-driven diagnostic imaging and robotic surgery platforms, secured major long-term equipment supply and maintenance contracts for large-scale Kuwait Ministry of Health hospital expansion projects, and strengthened its digital health and specialized oncology pharmaceutical supply chain capabilities.